Case details

Patent number:
EP2934582 - ANTI HER2 ANTIBODY FORMULATION,
EP3794032 - ANTI-OX40 ANTAGONISTIC ANTIBODIES FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
EP3999537 - LYOPHILIZED ANTIBODY FORMULATION,
EP3672637 - METHODS OF INACTIVATING VIRAL CONTAMINANTS,
EP3110950 - EXPRESSION CONSTRUCTS AND METHODS FOR SELECTING HOST CELLS EXPRESSING POLYPEPTIDES,
EP3867273 - T CELL REDIRECTING BISPECIFIC ANTIBODIES FOR THE TREATMENT OF SQUAMOUS CELL CANCERS,
EP3856347 - ANTIBODY QUANTIFICATION IN BIOLOGICAL SAMPLES,
EP3822366 - METHODS TO DETERMINE THE MONOCLONALITY OF A CELL POPULATION,
EP3615571 - T CELL REDIRECTING BISPECIFIC ANTIBODIES FOR THE TREATMENT OF EGFR POSITIVE CANCERS,
EP3849513 - COMPOSITIONS COMPRISING A BISPECIFIC ANTIBODY, BUFFFER AND ONE OR MORE STABILIZING AGENTS,
EP3786174 - METHODS FOR ANTIBODY PURIFICATION